Washington, DC - Today, we honor those who perished 77 years ago at Pearl Harbor, and we salute every veteran who served in World War II over the 4 years that followed that horrific attack.

Washington, DC - Remarks by President Trump and Vice President Pence at a Hanukkah Celebration:

Honolulu, Hawaii - Ikaika Erik Kang, 35, a Sergeant First Class in the U.S. Army formerly stationed at Schofield Barracks, was sentenced Tuesday to 25 years in prison for attempting to provide material support to the Islamic State of Iraq and al-Sham (ISIS), a designated foreign terrorist organization.  Kang was sentenced to 240 months on Counts 2, 3 and 4 to run concurrently, and 60 months on Count 1, to run consecutively, for a total of 300 months in prison.  As part of his sentence, Kang will serve 20 years of supervised release following his incarceration.

Miami, Florida - A Colombian national was sentenced to 180 months in prison for his role in a scheme to smuggle illegal aliens from Colombia into the United States, which resulted in the rape of one and the death of two Cuban nationals.

Manhattan, New York - Four individuals have been charged in an indictment unsealed Tuesday in the Southern District of New York with wire fraud, tax fraud, money laundering and other offenses in connection with their alleged roles in a decades-long criminal scheme perpetrated by Mossack Fonseca & Co. (“Mossack Fonseca”), a Panamanian-based global law firm, and related entities.

Washington, DC - “Blood and blood components are some of the most critical medical products American patients depend upon. The U.S. has one of the world’s safest blood supplies. But there remains risk, albeit uncommon, of contamination with infectious diseases, particularly with blood products that are stored at room temperature,” said FDA Commissioner Scott Gottlieb, M.D. “While we’ve made great strides in reducing the risk of blood contamination through donor screening and laboratory testing, we continue to support innovations and blood product alternatives that can better keep pace with emerging pathogens and reduce some of the logistical challenges and costs associated with ensuring the safety of blood products. In addition to microbial testing of blood, the application of safe and effective pathogen reduction technologies is an important part of the agency’s blood safety efforts.